Rare Muscle Disorders Eased by Heart Drug
Rare Muscle Disorders Eased by Heart Drug
Filed under: Drug Treatment Centers District of Columbia
The most common adverse events — most of them during active treatment – were gastrointestinal, and the single serious event was not related to the study drug, Barohn and colleagues reported in the Oct. 3 issue of the Journal of the American Medical …
Read more on MedPage Today
Hong Kong woman dies after cancer 'beauty' treatment
Filed under: Drug Treatment Centers District of Columbia
The 46-year-old died Wednesday morning at a local hospital one week after receiving DC-CIK therapy through the DR beauty center, local authorities said. According to the Hong Kong Health Department, the DC-CIK procedure involves the "concentration and …
Read more on CNN
Experimental therapy can slow Alzheimer's progress
Filed under: Drug Treatment Centers District of Columbia
Developers have halted development of the drug while the academic researchers continue to examine the data. On Monday, Reisa Sperling, director of the Center for Alzheimer's research and treatment at Brigham and Women's Hospital in Boston, reported …
Read more on The Tennessean
HIV in Corrections and Beyond: Progress and Challenges – Special Satellite Session from the Opening Day of the International AIDS Conference in Washington, DC Featuring: Honorable Mary Lou Leary, JD, Acting Assistant Attorney General, Office of Justice Programs, US Department of Justice Redonna K. Chandler, MD PhD, Chief of the Services Research Branch at the National Institute on Drug Abuse, National Institutes of Health Gregory Pappas, MD, PhD, Senior Deputy Director for HIV/AIDS, Hepatitis, STD, and TB Administration, Department of Health, District of Columbia Jerry Brown, EdD, Deputy Director, Office on Returning Citizen Affairs, District of Columbia This session highlights the critical work being done in the area of HIV prevention, diagnosis, and treatment among incarcerated populations – including linkage to care after release – by some of the nation’s top researchers in the field. Invited speakers also address the road ahead: shaping national priorities in HIV and correctional health from well-informed Public Health, Research, and Justice perspectives. Sponsored by the CFAR Collaboration on HIV in Corrections (CFAR-CHIC) steering group, EnhanceLink Working Group, Emory University/Abt Associates EnhanceLink Evaluation & Support Center, Center for Interdisciplinary Research on AIDS at Yale University, District of Columbia Developmental CFAR, Lifespan/Tufts/Brown CFAR, the University of North Carolina CFAR and Center for Prisoner Health and Human Rights (www.prisonerhealth.org). *Please note: the first two minutes of the …